- Whistleblower: Abbott off-label TriCor scheme put patients at risk
- Off-label promotion charges cost BI $95M in whistleblower deal
- Guilty: Amgen to pay $762M in latest off-label bust
- US: Novartis a 'repeat' kickback offender
ONLY 0 DAY LEFT
|Stay close to your market. Renew online now to ensure uninterrupted access to:|
|SCRIP Intelligence's news and expert commentary|
|Market Data and Company Analysis (SCRIP 100, SCRIP Asia 100)|
|The Ask the Analyst Service...and more.|
Please remember to quote your order number and customer number.
You can also renew by calling: +44 (0)20 7017 5540.